Study Completion Clause Samples
POPULAR SAMPLE Copied 1 times
Study Completion. For purposes of this Agreement, the Study is considered complete after conclusion of all Protocol-required activities for all enrolled subjects; receipt by ABC of all Protocol-required data; and receipt of all payments due to either party.
Study Completion. This Agreement will terminate when the Study is complete, which means the conclusion of all Protocol-required activities for all enrolled Study Subjects.
Study Completion. 1. The Sponsor shall, within 90 days of the study completion, inform the State Institute for Drug Control and relevant Ethics Committees on completion of the study. Provided the completion of the study has been aborted, above mentioned period shall be reduced to 15 days.
Study Completion. This Agreement will terminate when the Study is complete, which means the conclusion of all Study-required activities Early Termination of Study. This Agreement will terminate if the Study is terminated early as described below.
Study Completion. For purposes of this Agreement, the Study is considered complete after conclusion of all Protocol-required activities for all enrolled Study Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Study documents; and receipt of all payments due to either Party. b. Dokončení studie. Pro účely této smlouvy je studie považována za dokončenou po dokončení všech činností vyžadovaných protokolem u všech zařazených studijních subjektů; po obdržení všech příslušných protokolem vyžadovaných údajů, dokumentů studie zadavatelem nebo CRO a po obdržení všech plateb dlužných kterékoli ze stran.
Study Completion. The end of the study is defined as the date of database lock. The Investigator will notify the IRB/IEC when the study has been completed.
Study Completion. The Sponsor shall, within 90 days of the study completion, inform the State Institute for Drug Control and relevant Ethics Committees on completion of the study. Provided the completion of the study has been aborted, above mentioned period shall be reduced to 15 days. The Contract may be terminated as follows:
a) If at least one (1) Study subject has not been enrolled by the Key Enrollment Date then Sponsor may terminate this Contract in accordance with section 3 of this Article. Key Enrollment Date is defined as a 100th (hundredth) calendar day after Site Initiation Visit.
b) The Sponsor or the Health Service Provider is entitled to withdraw from the Contract that is effective on the day notice has been delivered to the last of parties in cases as follows:
(i) Any of the Contract parties does not meet some provision of this Contract and does not eliminate the discrepancies within 60 days after obtaining a written request to do so;
(ii) Any of the Contract parties performs settlement with its creditors or files a petition for bankruptcy;
(iii) Any of the Contract parties ceases to be authorised to pursue its activities within the field in concern;
(iv) The risk incurred by the subjects increases significantly; or
(v) The necessary authorisation, approval, consent or exception are revoked or suspended, or expires without prolongation.
c) The Contract may be terminated by written mutual agreement or notice, with the period of notice being 30 days from the day following the day of delivery of the notice to the last of Contract parties.
d) Sponsor may suspend enrolment or terminate this Contract effective immediately upon written notice.
Study Completion. This Agreement will terminate when the Study is
Study Completion. This Agreement will terminate when the Study is complete, which means the conclusion of all Study-required activities společnosti XXX veškerá práva a povinnosti, oznámí CRO nebo společnost XXX tuto skutečnost Poskytovateli a Hlavnímu zkoušejícímu písemně. CRO (nebo společnost XXX po postoupení práv a povinností CRO) je rovněž bez omezení oprávněn postoupit práva a povinnosti související s prováděním Studie externímu poskytovateli na základě předchozího oznámení adresovaného Poskytovateli a Hlavnímu zkoušejícímu a je oprávněn bez omezení postoupit svá povinnosti či práva týkající se provádění Studie jakékoli spřízněné osobě společnosti XXX. Bez písemného souhlasu Poskytovatele a Hlavního zkoušejícího není CRO oprávněno jinak postoupit svá práva nebo povinnosti z této Smlouvy. Pokud CRO nebo společnost XXX postoupí povinnosti nebo využije k jejich splnění služeb subdodavatelů, odpovídá i nadále vůči Poskytovateli za plnění těchto povinností CRO nebo společnost XXX. 18
Study Completion. 1. The Sponsor shall, within 90 days of the study completion, inform the State Institute for Drug Control and relevant Ethics Committees on completion of the study. Provided the completion of the study has been aborted, above mentioned period shall be reduced to 15 days.
2. The Contract may be terminated as follows:
a) If at least one (1) Study subject has not been enrolled by the Key Enrollment Date then Sponsor may terminate this Contract in accordance with section 3 of this Article. Key Enrollment Date is defined as a 100th (hundredth) calendar day after Site Initiation Visit.
b) The Sponsor or the Provider is entitled to withdraw from the Contract that is effective on the day notice has been delivered to the last of parties in cases as follows:
(i) Any of the Contract parties does not meet some provision of this Contract and does not eliminate the discrepancies within 60 days after obtaining a written request to do so;
(ii) Any of the Contract parties performs settlement with its creditors or files a petition for bankruptcy;
(iii) Any of the Contract parties ceases to be authorised to pursue its activities within the field in concern;
(iv) The risk incurred by the